Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1265-1274

  Cairns, M ^a   Cisse, B ^a,b   Sokhna, C ^c   Cames, C ^c   Simondon, K ^c   Ba, E H ^c   Trape, J F ^c   Gaye, O ^b   Greenwood, B M ^a   Milligan, P J M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; FANSIDAR; METAKELFIN;

ANTHROPOMETRY; ARTICLE; BODY WEIGHT; BOOTSTRAPPING; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG TOLERABILITY; FEVER; GROUPS BY AGE; HEADACHE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALARIA; MALARIA CONTROL; PRIORITY JOURNAL; PRURITUS; RASH; SENEGAL; VOMITING;

AGE FACTORS; AMODIAQUINE; ANTIMALARIALS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA; PYRIMETHAMINE; SEASONS; SULFADOXINE; TREATMENT OUTCOME;

EID: 77149173440     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01161-09     Document Type: Article

References (27)

1. Aponte, J. J., D. Schellenberg, A. Egan, A. Breckenridge, I. Carneiro, J. Critchley, I. Danquah, A. Dodoo, R. Kobbe, B. Lell, J. May, Z. Premji, et al. 2009. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomized, placebo-controlled trials. Lancet 374:1533-1542.
2. Barnes, K. I., W. M. Watkins, and N. J. White. 2008. Antimalarial dosing regimens and drug resistance. Trends Parasitol. 24:127-134.
3. Brasseur, P., P. Agnamey, O. Gaye, M. Cisse, M. Badiane, M. Vaillant, W. R. Taylor, and P. Olliaro. 2009. Dosing accuracy of artesunate and amodiaquine as treatment for falciparum malaria in Casamance, Senegal. Trop. Med. Int. Health 14:79-87.
4. Bukirwa, H., and J. Critchley. 2006. Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria. Cochrane Database Syst. Rev., article no. CD004966.
5. Cairns, M. E., R. D. Gosling, I. Carneiro, S. Gesase, J. F. Mosha, R. Hashim, H. Kaur, M. Lemnge, F. W. Mosha, B. M. Greenwood, and D. Chandramohan. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS ONE, in press.
6. Cisse, B., M. E. Cairns, E. Faye, O. Ndiaye, B. Faye, C. Cames, Y. Cheng, M. Ndiaye, A. Thiaw, K. Simondon, J. F. Trape, O. Faye, J. L. Ndiaye, O. Gaye, B. M. Greenwood, and P. J. M. Milligan. 2009. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for IPT to prevent malaria in children. PLoS One 4:e7164.
7. Committee on the Perspectives on the Role of Intermittent Preventive Treatment for Malaria in Infants. 2008. Assessment of the role of intermittent preventive treatment for malaria in infants: letter report. National Academies Press, Washington, DC.
8. Hatton, C. S., T. E. Peto, C. Bunch, G. Pasvol, S. J. Russell, C. R. Singer, G. Edwards, and P. Winstanley. 1986. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1:411-414.
9. Hwang, J., E. Bitarakwate, M. Pai, A. Reingold, P. J. Rosenthal, and G. Dorsey. 2006. Chloroquine or amodiaquine combined with sulfadoxinepyrimethamine for uncomplicated malaria: a systematic review. Trop. Med. Int. Health 11:789-799.
10. Molyneux, E., R. Brogan, G. Mitchell, and S. Gove. 1999. Children's weights: guess or measure by tape? Lancet 354:1616.
11. Neftel, K. A., W. Woodtly, M. Schmid, P. G. Frick, and J. Fehr. 1986. Amodiaquine induced agranulocytosis and liver damage. Br. Med. J. (Clin. Res. Ed.) 292:721-723.
12. Obonyo, C. O., E. A. Juma, B. R. Ogutu, J. M. Vulule, and J. Lau. 2007. Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisininbased combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis. Trans. R. Soc. Trop. Med. Hyg. 101:117-126.
13. Royston, P., and D. Altman. 1994. Using fractional polynomials to model curved regression relationships. Stata Tech. Bull. 21:11-23.
14. Sirima, S. B., A. B. Tiono, A. Gansane, A. Diarra, A. Ouedraogo, A. T. Konate, J. R. Kiechel, C. C. Morgan, P. L. Olliaro, and W. R. Taylor. 2009. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar. J. 8:48.
15. Sokhna, C., B. Cisse, E. H. Ba, P. Milligan, R. Hallett, C. Sutherland, O. Gaye, D. Boulanger, K. Simondon, F. Simondon, G. Targett, J. Lines, B. Greenwood, and J.-F. Trape. 2008. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 3:e1471.
16. Souares, A., R. Lalou, I. Sene, D. Sow, and J. Y. Le Hesran. 2008. Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. Trans. R. Soc. Trop. Med. Hyg. 102:751-758.
17. Taylor, W. R., D. J. Terlouw, P. L. Olliaro, N. J. White, P. Brasseur, and F. O. ter Kuile. 2006. Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Bull. World Health Organ. 84:956-964.
18. Taylor, W. R., and N. J. White. 2004. Antimalarial drug toxicity: a review. Drug Saf. 27:25-61.
19. Terlouw, D. J., J. M. Courval, M. S. Kolczak, O. S. Rosenberg, A. J. Oloo, P. A. Kager, A. A. Lal, B. L. Nahlen, and F. O. ter Kuile. 2003. Treatment history and treatment dose are important determinants of sulfadoxinepyrimethamine efficacy in children with uncomplicated malaria in Western Kenya. J. Infect. Dis. 187:467-476.
20. White, N. J. 2008. How antimalarial drug resistance affects post treatment prophylaxis. Malar. J. 7:9.
21. WHO Multicentre Growth Reference Study Group. 2006. WHO Child Growth Standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. World Health Organization, Geneva, Switzerland.
22. World Health Organization. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.
23. World Health Organization. 2001. The use of antimalarial drugs (WHO/CDS/RBM/2001.33). World Health Organization, Geneva, Switzerland.
24. Yeka, A., K. Banek, N. Bakyaita, S. G. Staedke, M. R. Kamya, A. Talisuna, F. Kironde, S. L. Nsobya, A. Kilian, M. Slater, A. Reingold, P. J. Rosenthal, F. Wabwire-Mangen, and G. Dorsey. 2005. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. 2:e190.
25. Zongo, I., G. Dorsey, N. Rouamba, C. Dokomajilar, M. Lankoande, J. B. Ouedraogo, and P. J. Rosenthal. 2005. Amodiaquine, sulfadoxine- pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Am. J. Trop. Med. Hyg. 73:826-832.
26. Zongo, I., G. Dorsey, N. Rouamba, C. Dokomajilar, Y. Sere, P. J. Rosenthal, and J. B. Ouedraogo. 2007. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin. Infect. Dis. 45:1453-1461.
27. Zongo, I., G. Dorsey, N. Rouamba, H. Tinto, C. Dokomajilar, R. T. Guiguemde, P. J. Rosenthal, and J. B. Ouedraogo. 2007. Artemether- lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet 369:491-498.